| RS2134129858 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS2134129924 |
EBF3
|
Health Risk |
Likely pathogenic |
Hypotonia, ataxia |
| RS2134131094 |
CAPRIN1
|
Health Risk |
Pathogenic |
CAPRIN1-related neurodevelopmental disorders, CAPRIN1-related neurodevelopmental disorders |
| RS2134149229 |
CNNM2
|
Health Risk |
Likely pathogenic |
Hypomagnesemia, seizures |
| RS2134149603 |
CNNM2
|
Health Risk |
Likely pathogenic |
Hypomagnesemia, seizures |
| RS2134151980 |
KMT2A
|
Health Risk |
Likely pathogenic |
KMT2A-related disorder, KMT2A-related disorder |
| RS2134152310 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2134152451 |
KMT2A
|
Health Risk |
Likely pathogenic |
— |
| RS2134152803 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2134153013 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, KMT2A-related disorder |
| RS2134159675 |
KAT6B
|
Health Risk |
Likely pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2134159699 |
KAT6B
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2134165271 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS2134165472 |
KAT6B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS2134166251 |
BLNK
|
Health Risk |
Pathogenic |
Agammaglobulinemia 4, autosomal recessive |
| RS2134168183 |
MYPN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1KK, MYPN-related myopathy |
| RS2134169278 |
KAT6B
|
Health Risk |
Pathogenic |
— |
| RS2134169413 |
MYPN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1KK, Dilated cardiomyopathy 1KK |
| RS2134170202 |
HPSE2
|
Health Risk |
Likely pathogenic |
— |
| RS2134175729 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Usher syndrome type 1D |
| RS2134191508 |
FAR1
|
Health Risk |
Pathogenic |
— |
| RS2134192926 |
MPDZ
|
Health Risk |
Likely pathogenic |
— |
| RS2134193085 |
FAR1
|
Health Risk |
Pathogenic |
— |
| RS2134198422 |
MYPN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1KK, Dilated cardiomyopathy 1KK |
| RS2134202766 |
APOA5
|
Health Risk |
Likely pathogenic |
— |
| RS2134204980 |
MYPN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1KK, Dilated cardiomyopathy 1KK |
| RS2134205727 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2134215546 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2134215591 |
TECTA
|
Health Risk |
Pathogenic |
— |
| RS2134215671 |
TECTA
|
Health Risk |
Pathogenic |
— |
| RS2134222531 |
CHUK
|
Health Risk |
Pathogenic |
— |
| RS2134229666 |
CHUK
|
Health Risk |
Pathogenic |
Bartsocas-Papas syndrome 2, Bartsocas-Papas syndrome 2 |
| RS2134230434 |
APOA1
|
Health Risk |
Pathogenic |
— |
| RS2134230655 |
APOA1
|
Health Risk |
Likely pathogenic |
Hypoalphalipoproteinemia, primary |
| RS2134231221 |
APOA1
|
Health Risk |
Likely pathogenic |
Hypoalphalipoproteinemia, primary |
| RS2134231440 |
APOA1
|
Health Risk |
Pathogenic |
Familial amyloid polyneuropathy, Iowa type |
| RS2134232474 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2134233729 |
APOA1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 50, Hypoalphalipoproteinemia |
| RS2134234642 |
KAT6B
|
Health Risk |
Likely pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2134234910 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2134235615 |
KAT6B
|
Health Risk |
Pathogenic |
— |
| RS2134235713 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2134235789 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2134236431 |
KAT6B
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2134237417 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Blepharophimosis - intellectual disability syndrome |
| RS2134239492 |
KAT6B
|
Health Risk |
Likely pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2134240152 |
KAT6B
|
Health Risk |
Likely pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS2134240789 |
KAT6B
|
Health Risk |
Pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS2134241204 |
KAT6B
|
Health Risk |
Likely pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS2134241318 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Genitopatellar syndrome |
| RS2134241950 |
KAT6B
|
Health Risk |
Pathogenic |
— |
| RS2134245408 |
KAT6B
|
Health Risk |
Likely pathogenic |
— |
| RS2134249204 |
KAT6B
|
Health Risk |
Pathogenic |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS2134249363 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2134250333 |
HPSE2
|
Health Risk |
Pathogenic |
Urofacial syndrome type 1, Urofacial syndrome type 1 |
| RS2134251199 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2134251305 |
AIP
|
Health Risk |
Pathogenic |
— |
| RS2134253269 |
HPS5
|
Health Risk |
Likely pathogenic |
— |
| RS2134253352 |
AIP
|
Health Risk |
Pathogenic |
— |
| RS2134253566 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, Pfeiffer syndrome |
| RS2134253609 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, FGFR2-related disorder |
| RS2134253669 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, FGFR2-related craniosynostosis |
| RS2134254345 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, FGFR2-related disorder |
| RS2134254562 |
FGFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
FGFR2-related craniosynostosis, Crouzon syndrome |
| RS2134254613 |
AIP
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2134254903 |
AIP
|
Health Risk |
Pathogenic |
— |
| RS2134255291 |
AIP
|
Health Risk |
Pathogenic |
— |
| RS2134256250 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, FGFR2-related craniosynostosis |
| RS2134256765 |
FGFR2
|
Health Risk |
Likely pathogenic |
— |
| RS2134257719 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2134258206 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2134259032 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2134260022 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, FGFR2-related disorder |
| RS2134260133 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134260983 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2134263074 |
SHANK2
|
Health Risk |
Likely pathogenic |
— |
| RS2134263239 |
KMT2A
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2134263745 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134264496 |
KMT2A
|
Health Risk |
Likely pathogenic |
— |
| RS2134264638 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2134265043 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134265865 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134266780 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Inborn genetic diseases |
| RS2134268054 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134268340 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134268457 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2134268866 |
KMT2A
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2134268900 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134269273 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2134270387 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134271140 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2134271637 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134271866 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134272176 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134272638 |
CWF19L1
|
Health Risk |
Likely pathogenic |
— |
| RS2134272841 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS2134273279 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS2134275180 |
SHANK2
|
Health Risk |
Likely pathogenic |
Autism, susceptibility to |
| RS2134275196 |
SHANK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autism spectrum disorder, Rare disease with autism |
| RS2134277047 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |